Kynam Capital Management, LP Beam Therapeutics Inc. Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
A detailed history of Kynam Capital Management, LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,417,647 shares of BEAM stock, worth $40.8 Million. This represents 4.91% of its overall portfolio holdings.
Number of Shares
2,417,647
Previous 2,518,170
3.99%
Holding current value
$40.8 Million
Previous $49.2 Million
16.38%
% of portfolio
4.91%
Previous 4.14%
Shares
4 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$169 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$164 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$149 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$129 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$79.7 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.19B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...